The purpose of this study is to evaluate whether extended prophylaxis with oral betrixaban
can prevent blood clots in the leg and lung that sometime occur in patients hospitalized for
an acute medical illness and to compare these results with standard of care enoxaparin. The
safety of betrixaban will also be studied.